SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+16.97%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.2B
AUM Growth
+$1.2B
(+6%)
Cap. Flow
-$60.2M
Cap. Flow
% of AUM
-5%
Top 10 Holdings %
Top 10 Hldgs %
37.95%
Holding
109
New
16
Increased
24
Reduced
36
Closed
22
Top Buys
| 1 |
Grifois
GRFS
|
$40.2M |
| 2 |
Sanofi
SNY
|
$31.7M |
| 3 |
QuidelOrtho
QDEL
|
$31.3M |
| 4 |
Eli Lilly
LLY
|
$17.1M |
| 5 |
Krystal Biotech
KRYS
|
$16.6M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$26M |
| 2 |
Nurix Therapeutics
NRIX
|
$22.2M |
| 3 |
Penumbra
PEN
|
$22.2M |
| 4 |
Vaxcyte
PCVX
|
$18.1M |
| 5 |
Humana
HUM
|
$16.6M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Viridian Therapeutics
VRDN
$1.5B
| $2.16M | 0.17% |
95,000
-245,000
| -72% | -$5.57M |
|
77
Adverum Biotechnologies
ADVM
$64.6M
| $2.02M | 0.16% |
287,246
+140,000
| +95% | +$983K |
|
78
CervoMed
CRVO
$83.7M
| $1.85M | 0.14% |
126,614
| – | – |
|
79
Veracyte
VCYT
$2.39B
| $1.85M | 0.14% |
+54,303
| New | +$1.85M |
|
|
BCYC
80
Bicycle Therapeutics
BCYC
$511M
| $1.77M | 0.14% |
78,315
+54,815
| +233% | +$1.24M |
|
81
GSK
GSK
$79.9B
| $1.53M | 0.12% |
37,500
-377,500
| -91% | -$15.4M |
|
|
ABVX
82
Abivax
ABVX
$6.12B
| $1.44M | 0.11% |
+125,000
| New | +$1.44M |
|
83
Olema Pharmaceuticals
OLMA
$375M
| $1.24M | 0.1% |
103,500
-113,000
| -52% | -$1.35M |
|
|
WHWK
84
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $686K | 0.05% |
333,227
| – | – |
|
85
Immunovant
IMVT
$2.56B
| $276K | 0.02% |
9,678
-242,222
| -96% | -$6.91M |
|
86
IO Biotech
IOBT
$104M
| $202K | 0.02% |
192,670
| – | – |
|
87
iRadimed
IRMD
$921M
| – | – |
-102,067
| Closed | -$4.48M |
|
88
Janux Therapeutics
JANX
$1.37B
| – | – |
-55,500
| Closed | -$2.32M |
|
89
Jazz Pharmaceuticals
JAZZ
$7.75B
| – | – |
-53,935
| Closed | -$5.76M |
|
90
MiMedx Group
MDXG
$1.05B
| – | – |
-82,884
| Closed | -$574K |
|
91
NovoCure
NVCR
$1.38B
| – | – |
-108,900
| Closed | -$1.87M |
|
92
Oric Pharmaceuticals
ORIC
$994M
| – | – |
-163,000
| Closed | -$1.15M |
|
|
93
Penumbra
PEN
$10.6B
| – | – |
-123,450
| Closed | -$22.2M |
|
94
Avita Medical
RCEL
$117M
| – | – |
-267,000
| Closed | -$2.11M |
|
95
The Beauty Health Co
SKIN
$264M
| – | – |
-1,604,718
| Closed | -$3.08M |
|
96
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
-586,499
| Closed | -$9.53M |
|
97
GeneDx Holdings
WGS
$3.72B
| – | – |
-87,000
| Closed | -$2.27M |
|
98
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
99
Xeris Biopharma Holdings
XERS
$1.26B
| – | – |
-62,083
| Closed | -$140K |
|
100
X4 Pharmaceuticals
XFOR
$84.2M
| – | – |
-4,051,000
| Closed | -$2.35M |
|